Know Cancer

or
forgot password

Engraftment Syndrome After Autologous Stem Cell Transplant: Retrospective Review in Patients With Multiple Myeloma


N/A
18 Years
N/A
Open (Enrolling)
Both
Multiple Myeloma

Thank you

Trial Information

Engraftment Syndrome After Autologous Stem Cell Transplant: Retrospective Review in Patients With Multiple Myeloma


A retrospective chart review series will be performed fpr subjects enrolled from 1/1/2006.


Inclusion Criteria:



- Patients with Multiple Myeloma, developing engraftment syndrome

Exclusion Criteria:

- Patients with Multiple Myeloma, with no features of engraftment syndrome

Type of Study:

Observational

Study Design:

Time Perspective: Retrospective

Outcome Measure:

number of patients developing Engraftment syndrome following stem cell transplant

Outcome Description:

A retrospective review where subjects medical records are studied for development of engraftment syndrome 6 months after stem cell transplant

Outcome Time Frame:

6 months post-transplant

Safety Issue:

Yes

Principal Investigator

Senu Apewokin, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

UAMS

Authority:

United States: Food and Drug Administration

Study ID:

UARK 2008-30

NCT ID:

NCT01622582

Start Date:

January 2006

Completion Date:

December 2013

Related Keywords:

  • Multiple Myeloma
  • Multiple Myeloma, Engraftment syndrome
  • Multiple Myeloma
  • Neoplasms, Plasma Cell

Name

Location

University of Arkansas for Medical SciencesLittle Rock, Arkansas  72205